Inici › Càncer de pulmó › Iowa › Cedar Rapids
Assaigs clínics de Càncer de pulmó a Cedar Rapids, IA
14 estudis de Càncer de pulmó busquen participants en centres de Cedar Rapids i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
ReclutantFase 3
- Physicians' Clinic of Iowa PC, Cedar Rapids
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutantEstudi observacionalVoluntaris sans benvinguts
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
ReclutantFase 3
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
ReclutantFase 3
- University of Iowa Hospitals & Clinics, Iowa City · a 25 mi
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
ReclutantFase 1/2
- Local Institution - 0065, Iowa City · a 25 mi
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
ReclutantFase 2/3
- Physicians Clinic of Iowa, Cedar Rapids
- Holden Comprehensive Cancer Center, University of Iowa Hospitals and Clinics, Iowa City · a 25 mi
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
ReclutantFase 3
- University of Iowa, Iowa City · a 25 mi
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
ReclutantFase 3
- Helen G. Nassif Community Cancer Center, Cedar Rapids
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
ReclutantFase 3
- Saint Luke's Hospital, Cedar Rapids
CHAMP Lung Cancer Screening Program
Reclutant
- University of Iowa, Iowa City · a 25 mi
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
ReclutantFase 1/2
- University of Iowa Health Care, Iowa City · a 25 mi
Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
ReclutantFase 2
- University of Iowa Hospitals and Clinics, Iowa City · a 25 mi
Using Xe MRI to Guide Radiation Therapy for Lung Cancer
ReclutantFase 2
- University of Iowa, Iowa City · a 25 mi
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutantEstudi observacional
- Massive Bio SYNERGY-AI site, Iowa City · a 25 mi
Assaigs de Càncer de pulmó en altres ciutats
- Houston, TX78 estudis
- Boston, MA62 estudis
- New York City, NY60 estudis
- Los Angeles, CA45 estudis
- Washington, DC41 estudis
- Arlington, VA41 estudis
- Chicago, IL41 estudis
- Nashville, TN40 estudis
- Baltimore, MD40 estudis
- St. Louis, MO39 estudis
- Columbus, OH37 estudis
- Philadelphia, PA36 estudis
Altres estudis a Cedar Rapids
- Càncer de pulmó de cèl·lules no petites20 estudis
- Càncer de mama17 estudis
- Leucèmia mieloide aguda16 estudis
- Càncer (tots els tipus)15 estudis
- Mieloma múltiple15 estudis
- Càncer colorrectal13 estudis
- Càncer de pròstata12 estudis
- Carcinoma de cèl·lules escamoses de cap i coll12 estudis
- Melanoma10 estudis
- Ictus10 estudis
- Càncer metastàtic9 estudis
- Càncer d'endometri9 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.